Triazole derivatives of structural formula I are selective inhibitors of the 11&bgr;-hydroxysteroid dehydrogenase-1. The compounds are useful for the treatment of diabetes, such as noninsulin-dependent diabetes (NIDDM), hyperglycemia, obesity, insulin resistance, dyslipidemia, hyperlipidemia, hypertension, Metabolic Syndrome, and other symptoms associated with NIDDM.
三唑衍
生物的结构式I是对11β-羟基类
固醇脱氢酶-1的选择性
抑制剂。这些化合物可用于治疗糖尿病,如非
胰岛素依赖型糖尿病(NID
DM)、高血糖、肥胖、
胰岛素抵抗、血脂异常、高脂血症、高血压、代谢综合征以及与非
胰岛素依赖型糖尿病相关的其他症状。